This fascinating short video interviews some of the top leukemia doctors around the world and looks at how tracking faulty chromosomes is now routine for people with chronic myeloid leukemia. Experts such as Dr Brian Druker and Prof. John Goldman explain what sophisticated laboratory tests can tell about treatment success:
Video
Sunday, July 20, 2008
Cancer: tracking progress for the treatment of CML
Labels:
cancer,
CML,
competitive intelligence,
Gleevec,
imatinib,
leukemia,
market intelligence,
market trends,
oncology
Subscribe to:
Post Comments (Atom)
1 comment:
Good blog..valuable,precious information..keep updating
Post a Comment